Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Intern Med ; 264(2): 143-54, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18331292

RESUMO

OBJECTIVES: The goal of the present study was to elucidate the contribution of the newly recognized virulence factor choline to the pathogenesis of Streptococcus pneumoniae in an animal model of meningitis. RESULTS: The choline containing strain D39Cho(-) and its isogenic choline-free derivative D39Cho(-)licA64--each expressing the capsule polysaccharide 2--were introduced intracisternally at an inoculum size of 10(3) CFU into 11 days old Wistar rats. During the first 8 h post infection both strains multiplied and stimulated a similar immune response that involved expression of high levels of proinflammatory cytokines, the matrix metalloproteinase 9 (MMP-9), IL-10, and the influx of white blood cells into the CSF. Virtually identical immune response was also elicited by intracisternal inoculation of 10(7) CFU equivalents of either choline-containing or choline-free cell walls. At sampling times past 8 h strain D39Cho(-) continued to replicate accompanied by an intense inflammatory response and strong granulocytic pleiocytosis. Animals infected with D39Cho(-) died within 20 h and histopathology revealed brain damage in the cerebral cortex and hippocampus. In contrast, the initial immune response generated by the choline-free strain D39Cho(-)licA64 began to decline after the first 8 h accompanied by elimination of the bacteria from the CSF in parallel with a strong WBC response peaking at 8 h after infection. All animals survived and there was no evidence for brain damage. CONCLUSION: Choline in the cell wall is essential for pneumococci to remain highly virulent and survive within the host and establish pneumococcal meningitis.


Assuntos
Parede Celular/química , Colina/fisiologia , Meningite Pneumocócica/imunologia , Streptococcus pneumoniae/patogenicidade , Fatores de Virulência/fisiologia , Animais , Colina/líquido cefalorraquidiano , Citocinas/líquido cefalorraquidiano , Citocinas/metabolismo , Modelos Animais de Doenças , Interleucina-10/metabolismo , Metaloproteinase 9 da Matriz/líquido cefalorraquidiano , Metaloproteinase 9 da Matriz/metabolismo , Meningite Pneumocócica/líquido cefalorraquidiano , Ratos , Ratos Wistar , Streptococcus pneumoniae/imunologia , Virulência
2.
FEMS Microbiol Lett ; 199(2): 241-6, 2001 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-11377874

RESUMO

Utilization of beta-glucosides is markedly variable in the members of the family Enterobacteriaceae. The results presented here provide molecular clues for evolutionary events that resulted in the phenotypic variability seen amongst the members of these species. The genomic hybridization of selected Enterobacteriaceae members with the Escherichia coli bgl and cel genes resulted in detection of a complete homolog of the bgl and cel operons in Shigella sonnei, a member that is evolutionarily closest to E. coli. However, the Salmonella group of organisms have been shown to carry only a homolog of bglR and bglG regions and the deletions of the bglF and bglB genes. Similarly, Proteus mirabilis, Enterobacter aerogenes and a non-enteric Gram-negative bacterium Pseudomonas aeruginosa have been shown to carry a homolog of the bglR and bglG regions and deletions of the bglF and bglB genes. The homolog of the cel operon could be identified in S. sonnei and Salmonella groups of organisms. Possible implications of these observations, in connection with the phenotypic variability seen in beta-glucoside utilization amongst these members, are discussed.


Assuntos
Proteínas de Bactérias , Enterobacteriaceae/patogenicidade , Glucosídeos/metabolismo , Proteínas Repressoras/metabolismo , Fatores de Transcrição/metabolismo , Enterobacteriaceae/genética , Enterobacteriaceae/metabolismo , Escherichia coli/genética , Fenótipo , Proteínas Repressoras/genética , Proteínas Repressoras/isolamento & purificação , Fatores de Transcrição/genética , Fatores de Transcrição/isolamento & purificação
3.
Acta Biochim Pol ; 46(4): 853-61, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10824852

RESUMO

SSOR, a clinical isolate of Shigella sonnei which exhibits a Salicin-negative phenotype, is unable to mutate to give rise to Sal+ derivatives although a homolog of the Escherichia coli bgl operon is retained by the strain. This was correlated to the presence of an endogenous plasmid in the strain. A plasmid-cured derivative, AK711, could give rise to Sal+ mutants in two steps. Introduction of the plasmid DNA, extracted from SSOR, into various strains of E. coli and S. sonnei, resulted in ampicillin resistant transformants. Interestingly, the presence of the plasmid suppressed the mutational activation of the bgl operon in the transformants. This was further substantiated by the observation that, transformants that have lost the plasmid regained the ability for mutational activation of the bgl operon. Preliminary characterisation of the plasmid indicated a size of 3.8 kb with an origin of replication resembling that of ColE1 replicons and the bla gene homolog of Tn3. Observations of the mutation frequency at the srl and lac loci in the presence of the plasmid indicate that there is a reduction in the mutation frequency, suggesting an antimutator activity associated with the plasmid.


Assuntos
Mutação , Óperon , Plasmídeos/genética , Shigella sonnei/genética , Escherichia coli/genética , Regulação Bacteriana da Expressão Gênica , Genes Bacterianos , Glucosídeos/metabolismo , Origem de Replicação , Shigella sonnei/metabolismo , Supressão Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...